S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
The "Smart Money" Is Ready for May 1st Are You? (Ad)
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Biden out June 13; Kamala won’t replace him? (Ad)
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Abbott Laboratories Outlook is Healthy: Buy the Dip
Top 5 AI Stocks to Buy for 2024 (Ad)
Stock market today: Asian shares gain despite Wall Street's tech-led retreat
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
The "Smart Money" Is Ready for May 1st Are You? (Ad)
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Biden out June 13; Kamala won’t replace him? (Ad)
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Abbott Laboratories Outlook is Healthy: Buy the Dip
Top 5 AI Stocks to Buy for 2024 (Ad)
Stock market today: Asian shares gain despite Wall Street's tech-led retreat
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
The "Smart Money" Is Ready for May 1st Are You? (Ad)
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Biden out June 13; Kamala won’t replace him? (Ad)
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Abbott Laboratories Outlook is Healthy: Buy the Dip
Top 5 AI Stocks to Buy for 2024 (Ad)
Stock market today: Asian shares gain despite Wall Street's tech-led retreat
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
The "Smart Money" Is Ready for May 1st Are You? (Ad)
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Biden out June 13; Kamala won’t replace him? (Ad)
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Abbott Laboratories Outlook is Healthy: Buy the Dip
Top 5 AI Stocks to Buy for 2024 (Ad)
Stock market today: Asian shares gain despite Wall Street's tech-led retreat
Prologis Stock Leading U.S. Logistics Boom
Free Trial
NASDAQ:HSGX

Histogenics (HSGX) Stock Price, News & Analysis

→ AI “wealth window” is closing soon! (From Paradigm Press) (Ad)
Free HSGX Stock Alerts
Notice: This company has been marked as potentially delisted and may not be actively trading.
Compare
Today's Range
$1.40
▼
$1.64
50-Day Range
$0.16
▼
$3.07
52-Week Range
$0.08
▼
$1.43
Volume
7.15 million shs
Average Volume
9.06 million shs
Market Capitalization
$136.22 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock AnalysisCompetitorsSocial Media
HSGX stock logo

About Histogenics Stock (NASDAQ:HSGX)

Histogenics Corporation develops restorative cell therapies that would offer rapid-onset pain relief and restored function. The company was founded in 2000 and is headquartered in Waltham, Massachusetts.

HSGX Stock News Headlines

April 8, 2023 | thetimes.co.uk
Feargal Sharkey: Desperate revival of failed policies doesn’t add up
September 21, 2022 | streetinsider.com
Aspect Biosystems Appoints Three New Board Members - StreetInsider.com
April 18, 2024 | Daily Market Alerts (Ad)
Top 5 Tech Stocks to Buy for 2024
Elon Musk just Triggered a BOOM in These Stocks Something strange is happening in the stock market…. This select group of stocks are going absolutely bananas. And it's all because of Elon Musk.
September 21, 2022 | businesswire.com
Aspect Biosystems Appoints Three New Board Members - Business Wire
August 24, 2022 | investing.com
Are Ocugen Or Amarin Good Stocks To Buy? - Investing.com
August 5, 2022 | stockhouse.com
2022-08-05 | NDAQ:OCGN | Press Release | Ocugen, Inc. - Stockhouse
June 23, 2022 | gurufocus.com
Ocugen Announces New Cell Therapy Program Following FDA Regenerative Medicine Advanced Therapy (RMAT) Recognition - GuruFocus.com
May 25, 2022 | uk.investing.com
Ocugen Diversifies Its Pipeline With New Cell Therapy Platform By Benzinga - Investing.com UK
April 18, 2024 | Daily Market Alerts (Ad)
Top 5 Tech Stocks to Buy for 2024
Elon Musk just Triggered a BOOM in These Stocks Something strange is happening in the stock market…. This select group of stocks are going absolutely bananas. And it's all because of Elon Musk.
May 25, 2022 | globenewswire.com
Ocugen Announces New Cell Therapy Program Following FDA Regenerative Medicine Advanced Therapy (RMAT) Recognition - GlobeNewswire
May 24, 2022 | streetinsider.com
Ocugen (OCGN) Announces New Cell Therapy Program Following FDA Regenerative Medicine Advanced Therapy (RMAT) Recognition - StreetInsider.com
April 18, 2022 | streetinsider.com
Form DEF 14A Aurinia Pharmaceuticals For: Apr 18 - StreetInsider.com
March 8, 2022 | investorplace.com
Ocugen Is Two Strikes in With a Third in the Books - InvestorPlace
October 26, 2021 | news.yahoo.com
CN.ORTH: New Blood on The Board - Yahoo Finance
September 21, 2021 | prnewswire.com
Global Cell Therapy Market Outlook, Patent & Clinical Trials Report 2021-2028: Clinical & Commercial Insight On 32 Cell Therapies Available & Insight on 1600+ Cell Therapies in Clinical Trials - PRNewswire
September 8, 2021 | streetinsider.com
Form 8-K APPLIED GENETIC TECHNOLO For: Sep 08 - StreetInsider.com
See More Headlines
Receive HSGX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Histogenics and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
8/09/2018
Today
4/17/2024
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Surgical Appliances & Supplies
Sub-Industry
N/A
Current Symbol
NASDAQ:HSGX
CUSIP
N/A
CIK
1372299
Web
www.histogenics.com
Phone
781-547-7900
Fax
N/A
Employees
49
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
($0.79)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-8,640,000.00
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-34.96%
Return on Assets
18.40%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
4.05
Quick Ratio
4.05

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($0.01) per share
Price / Book
-144.00

Miscellaneous

Outstanding Shares
94,599,000
Free Float
N/A
Market Cap
$136.22 million
Optionable
Not Optionable
Beta
3.10
A Guide To High-Short-Interest Stocks Cover
A Guide To High-Short-Interest Stocks

MarketBeat's analysts have just released their top five short plays for April 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

  • Mr. Adam D. Gridley (Age 47)
    Interim Pres, CEO Treasurer, Sec., Consultant & Director
  • Mr. Jonathan I. Lieber (Age 49)
    Interim Chief Financial Officer
  • Mr. Stephen R. Kennedy (Age 62)
    Consultant

Key Competitors

View All Competitors

HSGX Stock Analysis - Frequently Asked Questions

How were Histogenics' earnings last quarter?

Histogenics Corp (NASDAQ:HSGX) issued its earnings results on Thursday, August, 9th. The biotechnology company reported ($0.13) EPS for the quarter, beating analysts' consensus estimates of ($0.23) by $0.10.

What other stocks do shareholders of Histogenics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Histogenics investors own include Interpace Biosciences (IDXG), Novavax (NVAX), Verastem (VSTM), Progenics Pharmaceuticals (PGNX), SCYNEXIS (SCYX), Magnegas Applied Tchnlgy Sltns (MNGA), Ocular Therapeutix (OCUL), Trevena (TRVN), OPKO Health (OPK) and Synergy Pharmaceuticals (SGYP).

When did Histogenics IPO?

Histogenics (HSGX) raised $60 million in an initial public offering on Wednesday, December 3rd 2014. The company issued 4,300,000 shares at $13.00-$15.00 per share. Cowen and Company, Needham & Company and Canaccord Genuity served as the underwriters for the IPO and BTIG was co-manager.

This page (NASDAQ:HSGX) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners
[Urgent!] Generational Wealth Gameplan
Crypto 101 Media
He Is Giving Away Bitcoin
Crypto Swap Profits
The “Perfect Storm” for Gold
Gold Safe Exchange
Urgent alert: open this for a huge profit potential
Timothy Sykes
Top 5 AI Stocks to Buy for 2024
Market Moving Trends
Top 5 Tech Stocks to Buy for 2024
Daily Market Alerts
Biden out June 13; Kamala won’t replace him?
Paradigm Press
The #1 Crypto for 2024
InvestorPlace